PetMed Express stock reports earnings on November 10, 2026

Published on 10/17/2026 at 21:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue fell 4.21 percent in fiscal 2027 Q1. PetMed Express stock was USD 1.18 on October 16, 2026, down 3.28 percent versus the Nasdaq close.

Upcoming report and valuation

TradingView lists November 10, 2026 as PetMed Express's next earnings date.
Revenue fell 4.21 percent quarter over quarter to USD 41.02 million in fiscal 2027 Q1.
PetMed Express stock was USD 1.18 at 4:00 p.m. ET on October 16, 2026, down 3.28 percent versus the Nasdaq close of USD 1.22.
PetMed Express had a market capitalization of USD 25.6 million and a P/E ratio of minus 0.86.

PETS, US7163821066, Illustration mit AI erstellt.

PetMed Express is scheduled to report its next earnings on November 10, 2026, according to TradingView. Revenue fell 4.21 percent quarter over quarter to USD 41.02 million in fiscal 2027 Q1 from USD 42.82 million in fiscal 2026 Q4. On Nasdaq, the stock last traded at USD 1.18 on October 16, 2026 at 4:00 p.m. ET, down 3.28 percent versus the Nasdaq close of USD 1.22.

Revenue fell in fiscal 2027 Q1

The latest quarter ended June 30, 2026, with operating losses of USD 6.23 million and a net loss of USD 6.15 million. Diluted earnings per share were minus USD 0.28, compared with minus USD 0.19 in the preceding quarter. Operating cash flow was negative USD 7.69 million in fiscal 2027 Q1.

PetMed Express describes its business as a direct-to-consumer pet pharmacy selling prescription and over-the-counter medicines, food and related supplies through its website, contact center and other channels, according to PetMed Express.

The 52-week low is 2.61 percent away

The 52-week range was USD 1.15 to USD 4.10 as of October 16, 2026. The last Nasdaq price stood 2.61 percent above the low and 71.22 percent below the high. Trading volume reached 188,435 shares against an average of 114,029 shares, a 65.25 percent increase.

Valuation remains tightly linked to earnings

PetMed Express had a market capitalization of USD 25.6 million and a P/E ratio of minus 0.86 as of October 16, 2026. The company reported USD 13.08 million in cash at June 30, 2026, down from USD 21.41 million at March 31, 2026.

Comparison with peers

PetMed Express: minus 3.28 percent, P/E minus 0.86, market capitalization USD 25.6 million.
Chewy (NYSE, USD): minus 1.60 percent, P/E 31.77, market capitalization USD 8.4 billion.
Petco Health and Wellness (Nasdaq, USD): minus 2.31 percent, P/E 23.35, market capitalization USD 667.4 million.

What comes next for the stock

The November 10, 2026 reporting date gives investors the next fixed checkpoint for revenue, earnings and cash flow. The June quarter's negative operating cash flow and lower cash balance make the next report particularly relevant for assessing whether the business can stabilize its financial position.

On Nasdaq, PetMed Express last traded at USD 1.18 on October 16, 2026 at 4:00 p.m. ET, down 3.28 percent versus the Nasdaq close of USD 1.22.